CIBC Bancorp USA’s Exelixis EXEL Stock Holding History

CIBC Bancorp USA’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Buy	7,242 +1,297	+22%	+$63.1K	﹤0.01%	1397
2026 Q1	$258K	Buy	+5,945	New	+$256K	﹤0.01%	1484

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CIBC Bancorp USA's EXEL Position: Q2 2026 in Review

CIBC Bancorp USA increased its Exelixis (EXEL) stake by 22% in Q2 2026, buying an estimated $63.1K and bringing the position to 7,242 shares worth $394K. The position accounts for ﹤0.01% of the portfolio, ranked #1397.

CIBC Bancorp USA first reported a position in EXEL in Q1 2026 and has held it in 2 quarters since. 714 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

CIBC Bancorp USA held 7,242 shares of Exelixis worth $394K as of Q2 2026.
CIBC Bancorp USA bought 1,297 Exelixis shares in Q2 2026, an estimated $63.1K.
Exelixis made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1397 holding.
CIBC Bancorp USA first reported a position in Exelixis in Q1 2026 and has held it in 2 quarters since.
714 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.